Showing results (511-520 of 607) with videos related to

Sort By:
Pageof 61
Journal of Hepatology|January 23, 2021
A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCAJörn M Schattenberg, Albert Pares, Kris V Kowdley, et al.
Plos One|August 21, 2014
Sox17 regulates liver lipid metabolism and adaptation to fastingSamuel Rommelaere, Virginie Millet, Thien-Phong Vu Manh, et al.
Gastroenterology|November 26, 2015
Liver X Receptor Regulates Triglyceride Absorption Through Intestinal Down-regulation of Scavenger Receptor Class B, Type 1Olivier Briand, Véronique Touche, Sophie Colin, et al.
Cell Metabolism|August 4, 2015
The Bile Acid Chenodeoxycholic Acid Increases Human Brown Adipose Tissue ActivityEvie P M Broeders, Emmani B M Nascimento, Bas Havekes, et al.
Nature Medicine|July 16, 2013
Rev-erb-α modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagyEstelle Woldt, Yasmine Sebti, Laura A Solt, et al.
Iscience|January 17, 2022
Enterocyte superoxide dismutase 2 deletion drives obesityOihane Garcia-Irigoyen, Fabiola Bovenga, Marilidia Piglionica, et al.
Atherosclerosis|February 3, 2017
Anacetrapib, but not evacetrapib, impairs endothelial function in CETP-transgenic mice in spite of marked HDL-C increaseBranko Simic, Pavani Mocharla, Margot Crucet, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 20, 2008
Despite antiatherogenic metabolic characteristics, SCD1-deficient mice have increased inflammation and atherosclerosisMarcia L E MacDonald, Miranda van Eck, Reeni B Hildebrand, et al.
JHEP Reports : Innovation in Hepatology|February 22, 2021
NASH-related increases in plasma bile acid levels depend on insulin resistanceGuillaume Grzych, Oscar Chávez-Talavera, Amandine Descat, et al.
Pageof 61